{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:25:46Z","timestamp":1793172346451,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.suc.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T17:24:49Z","timestamp":1667496289000},"page":"947-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lobular Neoplasia"],"prefix":"10.1016","volume":"102","author":[{"given":"Lilia","family":"Lunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Coogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia B.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2022.07.001_bib1","volume":"vol. 2","author":"Lakhani","year":"2019"},{"key":"10.1016\/j.suc.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","article-title":"A\u00a0prospective study of benign breast disease and the risk of breast cancer","volume":"267","author":"London","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2022.07.001_bib3","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast: a long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2022.07.001_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/bcr624","article-title":"The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in\u00a0situ","volume":"5","author":"Simpson","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.suc.2022.07.001_bib5","series-title":"Neoplastic diseases: a textbook on tumors","author":"Ewing","year":"1919"},{"key":"10.1016\/j.suc.2022.07.001_bib6","first-page":"491","article-title":"Lobular carcinoma in situ. A rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/1078-0432.CCR-18-1103","article-title":"Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.suc.2022.07.001_bib9","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/bcr3222","article-title":"Clonal relatedness between lobular carcinoma in\u00a0situ and synchronous malignant lesions","volume":"14","author":"Andrade","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.suc.2022.07.001_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-016-0727-z","article-title":"Clonal relationships between lobular carcinoma in\u00a0situ and other breast malignancies","volume":"18","author":"Begg","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"10","key":"10.1016\/j.suc.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0046-8177(92)90026-Y","article-title":"Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia","volume":"23","author":"Page","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/modpathol.2011.66","article-title":"Atypical ductal hyperplasia: interobserver and intraobserver variability","volume":"24","author":"Jain","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib14","series-title":"Breast Tumours","first-page":"71","article-title":"Lobular carcinoma in\u00a0situ","author":"Chen","year":"2019"},{"issue":"11","key":"10.1016\/j.suc.2022.07.001_bib15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in\u00a0situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.suc.2022.07.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2214\/ajr.157.2.1853802","article-title":"Lobular carcinoma in\u00a0situ of the breast: clinical, pathologic, and mammographic features","volume":"157","author":"Beute","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.suc.2022.07.001_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.breast.2016.03.004","article-title":"The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project","volume":"27","author":"Maxwell","year":"2016","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.suc.2022.07.001_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0046-8177(92)90321-S","article-title":"Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation","volume":"23","author":"Eusebi","year":"1992","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.suc.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in\u00a0situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.suc.2022.07.001_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2010.08.010","article-title":"Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma","volume":"41","author":"Alvarado-Cabrero","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.suc.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and florid lobular carcinoma in\u00a0situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.suc.2022.07.001_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/modpathol.3800362","article-title":"E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast","volume":"18","author":"Mastracci","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability","volume":"106","author":"Sarrio","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.suc.2022.07.001_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ccr.2006.09.013","article-title":"Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis","volume":"10","author":"Derksen","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.suc.2022.07.001_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.2629","article-title":"The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type","volume":"220","author":"Weigelt","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib28","first-page":"4721","article-title":"Comparative genomic hybridization analysis of lobular carcinoma in\u00a0situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia","volume":"58","author":"Lu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.suc.2022.07.001_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.suc.2022.07.001_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.suc.2022.07.001_bib31","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in\u00a0situ and lobular carcinoma in\u00a0situ, 1988\u20132001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"issue":"9805","key":"10.1016\/j.suc.2022.07.001_bib32","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","article-title":"Gene expression profiling in breast cancer: classification, prognostication, and prediction","volume":"378","author":"Reis-Filho","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2022.07.001_bib35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"issue":"33","key":"10.1016\/j.suc.2022.07.001_bib36","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk","volume":"33","author":"King","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2022.07.001_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Lobular neoplasia. Long term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2022.07.001_bib38","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: Analysis of Surveillance, Epidemiology, and End Results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.001_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cncr.29775","article-title":"Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies","volume":"122","author":"Collins","year":"2016","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.suc.2022.07.001_bib40","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/cncr.30153","article-title":"Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women","volume":"122","author":"Degnim","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib41","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","article-title":"The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS","volume":"27","author":"Valero","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"10.1016\/j.suc.2022.07.001_bib42","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.14.8833","article-title":"Assessment of the accuracy of the Gail model in women with atypical hyperplasia","volume":"26","author":"Pankratz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1524-4741.1999.00002.x","article-title":"Lobular carcinoma in\u00a0situ of the breast","volume":"5","author":"Frykberg","year":"1999","journal-title":"Breast J"},{"key":"10.1016\/j.suc.2022.07.001_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast: A review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib45","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","article-title":"Trends in incidence and management of lobular carcinoma in\u00a0situ: A population-based analysis","volume":"20","author":"Portschy","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib47","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/modpathol.2008.134","article-title":"Atypical lobular hyperplasia and classic lobular carcinoma in\u00a0situ in core biopsy specimens: routine excision is not necessary","volume":"21","author":"Hwang","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00428-008-0607-8","article-title":"The significance of lobular neoplasia on needle core biopsy of the breast","volume":"452","author":"Menon","year":"2008","journal-title":"Virch Arch"},{"key":"10.1016\/j.suc.2022.07.001_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/jcp.2010.081687","article-title":"Management of in\u00a0situ lobular neoplasia detected on needle core biopsy of breast","volume":"63","author":"Purdie","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib50","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2214\/AJR.11.8447","article-title":"Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?","volume":"199","author":"Niell","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.suc.2022.07.001_bib51","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-011-2034-3","article-title":"Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy","volume":"19","author":"Rendi","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib52","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","article-title":"Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in\u00a0situ) diagnosed on core needle biopsy","volume":"19","author":"Shah-Khan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.13121730","article-title":"Atypical lobular hyperplasia and lobular carcinoma in\u00a0situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation","volume":"269","author":"Atkins","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.suc.2022.07.001_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/modpathol.2012.221","article-title":"Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy","volume":"26","author":"Chaudhary","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in\u00a0situ and atypical lobular hy- perplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.suc.2022.07.001_bib56","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/modpathol.2016.127","article-title":"Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review","volume":"29","author":"Mooney","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib57","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020)","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib58","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2214\/AJR.15.15425","article-title":"Core breast biopsies showing lobular carcinoma in\u00a0situ should be excised and surveillance is reasonable for atypical lobular hyperplasia","volume":"207","author":"Sen","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.suc.2022.07.001_bib59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.suc.2022.07.001_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5858\/arpa.2017-0155-OA","article-title":"Isolated atypical lobular hyperplasia diagnosed on breast biopsy: low upgrade rate on subse- quent excision with long-term follow-up","volume":"142","author":"Muller","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-017-4629-2","article-title":"Observation versus excision of lobular neoplasia on core needle biopsy of the breast","volume":"168","author":"Schmidt","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.suc.2022.07.001_bib62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.5858\/arpa.2018-0232-OA","article-title":"Triaging Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Percutaneous Core Biopsy to Surgery or Observation: Assiduous Radiologic-Pathologic Correlation Works, Quantitating Extent of Disease Does Not","volume":"143","author":"Holbrook","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib63","first-page":"573","article-title":"Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high risk breast lesion conferences at an academic institution. Breast cancer research and","volume":"185","author":"Li","year":"2021","journal-title":"treatment"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib64","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.surg.2020.07.025","article-title":"Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in\u00a0situ","volume":"169","author":"Pride","year":"2021","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.suc.2022.07.001_bib65","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-021-10827-z","article-title":"Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision","volume":"29","author":"Laws","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1245\/s10434-018-6937-0","article-title":"Evaluating the rate of upgrade to invasive breast cancer and\/or ductal carcinoma in\u00a0situ following a core biopsy diagnosis of non-classic lobular carcinoma in\u00a0situ","volume":"26","author":"Nakhlis","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2022.07.001_bib67","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41379-021-00796-9","article-title":"Morphologic subtypes of lobular carcinoma in\u00a0situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision","volume":"34","author":"Kuba","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.suc.2022.07.001_bib68","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in\u00a0situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","article-title":"Clinical implications of margin involvement by pleomorphic lobular carcinoma in\u00a0situ","volume":"135","author":"Downs-Kelly","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.suc.2022.07.001_bib70","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in\u00a0situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.suc.2022.07.001_bib71","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in\u00a0situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.suc.2022.07.001_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/tbj.12062","article-title":"Breast surgeon\u2019s survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in\u00a0situ","volume":"19","author":"Blair","year":"2013","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0360-3016(97)00573-7","article-title":"Lobular carcinoma in\u00a0situ as a component of breast cancer: the long-term outcome in patients treated with breast conservation therapy","volume":"40","author":"Moran","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suc.2022.07.001_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in\u00a0situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology"},{"issue":"3 Pt A","key":"10.1016\/j.suc.2022.07.001_bib75","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.suc.2022.07.001_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.breast.2017.04.005","article-title":"MRI surveillance for women with dense breasts and a previous breast cancer and\/or high risk lesion","volume":"34","author":"Nadler","year":"2017","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-013-2725-5","article-title":"Is there a role for routine screening MRI in women with LCIS?","volume":"142","author":"King","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.suc.2022.07.001_bib79","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1158\/1078-0432.CCR-07-0689","article-title":"BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials","volume":"13","author":"Tilanus-Linthorst","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.suc.2022.07.001_bib80","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"23","key":"10.1016\/j.suc.2022.07.001_bib81","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.suc.2022.07.001_bib82","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10218","key":"10.1016\/j.suc.2022.07.001_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"IBIS-II investigators. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2022.07.001_bib84","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/1940-6207.CAPR-17-0162","article-title":"A\u00a0survey among breast cancer specialists on the low uptake of therapeutic prevention with tamoxifen or raloxifene","volume":"11","author":"Noonan","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.suc.2022.07.001_bib85","doi-asserted-by":"crossref","first-page":"djv365","DOI":"10.1093\/jnci\/djv365","article-title":"Symptoms and QOL as predictors of chemoprevention adherence in NRG Oncology\/NSABP Trial P-1","volume":"108","author":"Land","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2022.07.001_bib86","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib87","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10434-001-0580-9","article-title":"Patient reluctance toward tamoxifen use for breast cancer primary prevention","volume":"8","author":"Port","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.07.001_bib88","doi-asserted-by":"crossref","first-page":"927","DOI":"10.6004\/jnccn.2015.0107","article-title":"Barriers to the use of breast cancer risk reduction therapies","volume":"13","author":"Bambhroliya","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.suc.2022.07.001_bib89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/1940-6207.CAPR-17-0314","article-title":"A\u00a0System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ","volume":"11","author":"Brewster","year":"2018","journal-title":"Cancer Prev Res"},{"issue":"19","key":"10.1016\/j.suc.2022.07.001_bib90","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.suc.2022.07.001_bib91","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1245\/s10434-018-6495-5","article-title":"Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database","volume":"25","author":"Taylor","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2022.07.001_bib92","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archinte.165.5.516","article-title":"A\u00a0population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices","volume":"165","author":"Geiger","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.suc.2022.07.001_bib93","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12032-013-0481-3","article-title":"Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution","volume":"30","author":"Sakurai","year":"2013","journal-title":"Med Oncol"},{"issue":"2","key":"10.1016\/j.suc.2022.07.001_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jamasurg.2017.3422","article-title":"Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study","volume":"153","author":"Jakub","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suc.2022.07.001_bib95","series-title":"Textbook of complex general surgical oncology","author":"Balch","year":"2016"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092200069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092200069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:14:52Z","timestamp":1758539692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003961092200069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S003961092200069X"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2022.07.001","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lobular Neoplasia","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}